Oral melanomas are the most frequent tumors of the mouth in our dog patients. Even if treated with very aggressive therapies, they often lead to the animal's death.
A new vaccine, developed and commercialized in the United States, offers a completely new therapeutic approach and promises much longer survival times.
The AOI Center was the first European oncological institute that was authorized to import and use this vaccine.
Superficial tumors: new immunotherapy
We apply a novel immunotherapy in the context of a clinical study in collaboration with the ETH Zürich. Don't hesitate to contact us for further information: